Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Shriram Finance, Piramal Pharma shares on 6 July
Indian benchmark indices, Sensex and Nifty 50, opened higher on July 6, driven by gains in private banking stocks following strong quarterly updates from HDFC Bank and Axis Bank. Market breadth was positive with 14 of the 16 major indices in the green.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
Stocks in news: HDFC Bank, Vedanta Power, YES Bank, Sun Pharma, Waaree Energies
Indian markets surged for a third straight day, buoyed by global sentiment and strong performance from heavyweight stocks like HDFC Bank and YES Bank. Analysts note a technical breakout, though resistance looms. Several companies, including Dabur India and Vedanta Power, reported positive quarterly updates, while Tata Power withdrew a controversial distribution application. ONGC's leadership eligibility criteria have also been broadened.
Sensex gains 579 points, Nifty ends above 24,150: 5 reasons why stock market rose today
Indian indices rose, Sensex up 579 pts, Nifty above 24,150, led by IT stocks, oil companies. Bank of Baroda fell on NMC Health settlement.
Stocks to Watch for July 2: Coal India, Bharti Airtel, NMDC, Lupin, Indian Bank and more
From Bharti Airtel's NBFC launch to Lupin's EMA approval and Coal India's operational update, here are the stocks to track ahead of Thursday's trading session.
SBI Securities prefers HDFC Bank, sees long-term upside in metals
Sunny Agarwal, Head Fundamental Research, Retail Desk at SBI Securities, remains positive on private banks, preferring HDFC Bank over Kotak Mahindra Bank after the lender received a clean legal review. He says Persistent Systems' acquisition benefits may take up to eight quarters to materialise, while slower growth remains a near-term concern. Agarwal is also bullish on the metals sector, with Indian Metals & Ferro Alloys as his top pick, and remains positive on Astral over the long term despite near-term challenges.
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent Systems
Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving averages, with a decisive close above 24,200 crucial for further gains. Several companies like Waaree Energies, Kotak Bank, and Tata Motors are in focus due to significant developments, including US investigations, strategic partnerships, and EV expansion plans.
Firm strength in dollar offsets gains in INR made from positive equities and easing oil prices
The Indian rupee depreciated 34 paise to close at 94.67 (provisional) against the US dollar on Monday, weighed down by the strength of the American currency in the overseas market. Rupee witnessed volatility as steady debt and deposit inflows pulled the domestic currency in one way, while the lack of clarity on the Middle East peace deal and a firm dollar pulled it the other way. The Indian stock market, which snapped a five-day winning streak on Friday, rebounded and closed higher on Monday, lifted by gains in technology, healthcare and oil sectors. The mood in the market remained positive amid reports of progress in US-Iran peace talks. Additionally, weak oil prices eased concerns about inflation. The benchmark BSE Sensex closed up by 291.17 points or 0.38% at 77,094.07 after scaling a low of 77,160.67 and a high of 77,325.56 intraday. At the interbank foreign exchange market, the rupee opened at 94.42, registering a decline of 9 paise from its previous close. In intraday trade, ...
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.
FPIs get tax relief on gilts, ease of Investment
In a strategic step to lure foreign investment, India has eliminated taxes on capital gains and interest for overseas investors in its government bonds. This change, set to take effect on April 1, is part of an ordinance aimed at enhancing the appeal of Indian sovereign bonds and fortifying the strength of the rupee.
Ipca Laboratories among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish momentum as their RSI crossed above 50, signaling potential upward price movement.
Trading ideas today: South Indian Bank, Suryoday SFB, Apollo Hospitals
Kunal Kamble of Bonanza has recommended three stocks to buy today - Suryoday Small Finance Bank, South Indian Bank and Apollo Hospitals.